$MLAB
MESA LABORATORIES INC /CO/ Stock $mlab

$mlab Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000143774924033745 Filed on November 07, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$57.83M	$53.17M
YoY Change		8.78%	-9.5%
Cost Of Revenue		$22.38M	$21.06M
YoY Change		6.28%	-5.84%
Gross Profit		$35.46M	$32.11M
YoY Change		10.42%	-11.75%
Gross Profit Margin		61.31%	60.39%
Selling, General & Admin		$23.44M	$27.18M
YoY Change		-13.77%	-0.82%
% of Gross Profit		66.1%	84.64%
Research & Development		$4.634M	$4.993M
YoY Change		-7.19%	0.08%
% of Gross Profit		13.07%	15.55%
Depreciation & Amortization		$1.518M	$8.100M
YoY Change		-81.26%	0.56%
% of Gross Profit		4.28%	25.23%
Operating Expenses		$31.95M	$32.17M
YoY Change		-0.69%	-0.69%
Operating Profit		$3.508M	-$60.00K
YoY Change		-5946.67%	-101.5%
Interest Expense		-$3.018M	$905.0K
YoY Change		-433.48%	-25.45%
% of Operating Profit		-86.03%
Other Income/Expense, Net		$304.0K	-$1.265M
YoY Change		-124.03%	107.04%
Pretax Income		$3.812M	-$1.325M
YoY Change		-387.7%	-139.15%
Income Tax		$384.0K	-$95.00K
% Of Pretax Income		10.07%
Net Earnings		$3.428M	-$1.230M
YoY Change		-378.7%	-194.18%
Net Earnings / Revenue		5.93%	-2.31%
Basic Earnings Per Share		$0.63	-$0.23
Diluted Earnings Per Share		$0.63	-$0.23
COMMON SHARES
Basic Shares Outstanding	5.431M	5.409M	5.384M
Diluted Shares Outstanding		5.471M	5.387M

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.34M	$35.60M
YoY Change	-31.64%	9.95%
Cash & Equivalents	$24.34M	$35.62M
Short-Term Investments
Other Short-Term Assets	$3.922M	$4.235M
YoY Change	-7.39%	19.6%
Inventory	$29.74M	$32.88M
Prepaid Expenses
Receivables	$40.23M	$36.34M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$108.0M	$117.7M
YoY Change	-8.23%	1.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.07M	$28.57M
YoY Change	12.25%	1.25%
Goodwill	$183.8M	$283.3M
YoY Change	-35.13%	1.89%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$20.14M	$8.953M
YoY Change	124.97%	-17.29%
Total Long-Term Assets	$346.1M	$519.5M
YoY Change	-33.38%	-3.79%
TOTAL ASSETS
Total Short-Term Assets	$108.0M	$117.7M
Total Long-Term Assets	$346.1M	$519.5M
Total Assets	$454.1M	$637.2M
YoY Change	-28.73%	-2.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.988M	$4.810M
YoY Change	24.49%	-37.84%
Accrued Expenses	$22.87M	$12.34M
YoY Change	85.34%	-0.96%
Deferred Revenue	$14.41M	$14.32M
YoY Change	0.67%	3.51%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$100.8M
YoY Change
Total Short-Term Liabilities	$153.2M	$39.82M
YoY Change	284.85%	-4.07%
LONG-TERM LIABILITIES
Long-Term Debt	$104.2M	$170.7M
YoY Change	-38.96%	-13.27%
Other Long-Term Liabilities	$14.65M	$5.443M
YoY Change	169.21%	-20.26%
Total Long-Term Liabilities	$14.65M	$5.443M
YoY Change	169.21%	-20.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$153.2M	$39.82M
Total Long-Term Liabilities	$14.65M	$5.443M
Total Liabilities	$292.6M	$249.4M
YoY Change	17.33%	-11.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$178.4M	$70.70M
YoY Change	-352.35%	-5.54%
Common Stock	$349.5M	$337.9M
YoY Change	3.45%	3.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$161.5M	$387.8M
YoY Change
Total Liabilities & Shareholders Equity	$454.1M	$637.2M
YoY Change	-28.73%	-2.9%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	$3.428M	-$1.230M
YoY Change	-378.7%	-194.18%
Depreciation, Depletion And Amortization	$1.518M	$8.100M
YoY Change	-81.26%	0.56%
Cash From Operating Activities	$5.271M	$9.780M
YoY Change	-46.1%	-7.36%
INVESTING ACTIVITIES
Capital Expenditures	$1.788M	$630.0K
YoY Change	183.81%	-138.44%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.788M	-$630.0K
YoY Change	183.81%	-61.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-8.610M	-5.560M
YoY Change	54.86%	-70.18%
NET CHANGE
Cash From Operating Activities	5.271M	9.780M
Cash From Investing Activities	-1.788M	-630.0K
Cash From Financing Activities	-8.610M	-5.560M
Net Change In Cash	-5.127M	3.590M
YoY Change	-242.81%	-136.9%
FREE CASH FLOW
Cash From Operating Activities	$5.271M	$9.780M
Capital Expenditures	$1.788M	$630.0K
Free Cash Flow	$3.483M	$9.150M
YoY Change	-61.93%	-24.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Address Address Line1 EntityAddressAddressLine1	12100 West Sixth Avenue
	dei	Entity Registrant Name EntityRegistrantName	MESA LABORATORIES INC /CO
	dei	Entity Central Index Key EntityCentralIndexKey	0000724004
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1026000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1321000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25656000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22519000	usd
CY2024Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5419855
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5419855
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5394491
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5394491
CY2024Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.16
CY2024Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.16
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Trd Arr Ind Title TrdArrIndTitle	Chief Executive Officer
CY2024Q3	ecd	Trd Arr Ind Name TrdArrIndName	Gary Owens
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	true
CY2024Q3	ecd	Trd Arr Adoption Date TrdArrAdoptionDate	September 12, 2024
CY2024Q3	ecd	Trd Arr Securities Agg Avail Amt TrdArrSecuritiesAggAvailAmt	30939000
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-11740
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-0872291
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lakewood
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80228
	dei	City Area Code CityAreaCode	303
	dei	Local Phone Number LocalPhoneNumber	987-8000
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	MLAB
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5431424
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24337000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28214000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40234000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39055000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	29738000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	32675000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13669000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9408000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	107978000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	109352000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32073000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31766000	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1329000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1292000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20142000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10538000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	183753000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	180096000	usd
CY2024Q3	us-gaap	Assets Assets	454098000	usd
CY2024Q1	us-gaap	Assets Assets	446796000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5988000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6041000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9185000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9935000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14412000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15478000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	22866000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12858000	usd
CY2024Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	3750000	usd
CY2024Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	0	usd
CY2024Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	97029000	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	153230000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	44312000	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	20561000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	19780000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14653000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15613000	usd
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	35500000	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	50500000	usd
CY2024Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	68703000	usd
CY2024Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	0	usd
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2024Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	171198000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	292647000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	301403000	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	349529000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	343642000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178407000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183494000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9671000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14755000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	161451000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	145393000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	454098000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	446796000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	22378000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	21056000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	43299000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	40518000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	35455000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	32109000	usd
	us-gaap	Gross Profit GrossProfit	72704000	usd
	us-gaap	Gross Profit GrossProfit	63292000	usd
CY2024Q3	us-gaap	Selling Expense SellingExpense	9849000	usd
CY2023Q3	us-gaap	Selling Expense SellingExpense	9650000	usd
	us-gaap	Selling Expense SellingExpense	19965000	usd
	us-gaap	Selling Expense SellingExpense	18626000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4634000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4993000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9369000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9804000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	31947000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	32169000	usd
	us-gaap	Operating Expenses OperatingExpenses	63616000	usd
	us-gaap	Operating Expenses OperatingExpenses	64016000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3508000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-60000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	9088000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-724000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3018000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	905000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	5860000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1953000	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3197000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3322000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-360000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1292000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	415000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	304000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1265000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1371000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1538000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3812000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1325000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7717000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2262000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	384000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-95000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	901000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-483000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	3428000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1230000	usd
	us-gaap	Net Income Loss NetIncomeLoss	6816000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1779000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5413000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5387000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5405000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5379000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5471000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5387000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5448000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5379000
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3428000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1230000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6816000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1779000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4632000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1353000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5084000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8014000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8060000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2583000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11900000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9793000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	145393000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	571000	usd
CY2024Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	863000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2928000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	452000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	3388000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	150727000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	307000	usd
CY2024Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	866000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3837000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4632000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	3428000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	161451000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	393480000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	52000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	712000	usd
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	859000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2968000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6661000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-549000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	387719000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	304000	usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2000	usd
CY2023Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	862000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3183000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1353000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1230000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	387759000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6816000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1779000	usd
	us-gaap	Depreciation Depreciation	2922000	usd
	us-gaap	Depreciation Depreciation	1825000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8611000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14405000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6765000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6151000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3197000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
	mlab	Amortization Of Inventory Stepup Cost AmortizationOfInventoryStepupCost	1232000	usd
	mlab	Amortization Of Inventory Stepup Cost AmortizationOfInventoryStepupCost	0	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1100000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1598000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	566000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5448000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	44000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	184000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1449000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3528000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-189000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1307000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2788000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1743000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1309000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1171000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15704000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19715000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2679000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	904000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2679000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-904000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	73465000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	16875000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	13000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	71250000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	1729000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	1721000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1330000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-358000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17719000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15079000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	817000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1025000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3877000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2707000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28214000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32910000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24337000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35617000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9658000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	991000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	57833000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53165000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	116003000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103810000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	57833000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53165000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	116003000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103810000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15686000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-6802000	usd
	mlab	Contract With Customer Liability Increase During Period Net Of Revenue Recognized ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized	5636000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14520000	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	18215000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	18335000	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	366000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1256000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11157000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13084000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	29738000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	32675000	usd
CY2024Q3	mlab	Prepaid Expenses Current PrepaidExpensesCurrent	3674000	usd
CY2024Q1	mlab	Prepaid Expenses Current PrepaidExpensesCurrent	2932000	usd
CY2024Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1666000	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1898000	usd
CY2024Q3	us-gaap	Prepaid Taxes PrepaidTaxes	4407000	usd
CY2024Q1	us-gaap	Prepaid Taxes PrepaidTaxes	1237000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	3922000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3341000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13669000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9408000	usd
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	4224000	usd
CY2024Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3838000	usd
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2404000	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3072000	usd
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2029000	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1956000	usd
CY2024Q3	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	528000	usd
CY2024Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1069000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9185000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9935000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3488000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2986000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1386000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1615000	usd
CY2024Q3	mlab	Acquisitionrelated Holdbacks Current AcquisitionrelatedHoldbacksCurrent	9891000	usd
CY2024Q1	mlab	Acquisitionrelated Holdbacks Current AcquisitionrelatedHoldbacksCurrent	436000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2193000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2264000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	22866000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12858000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	1518000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	911000	usd
	us-gaap	Depreciation Depreciation	2922000	usd
	us-gaap	Depreciation Depreciation	1825000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	257251000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	148428000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	108823000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	251072000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	137320000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	113752000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4550000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7185000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8611000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14405000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	9118000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	17586000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	16915000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	16301000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	15729000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	180096000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	3657000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	183753000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1875000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3750000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5625000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5625000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	7500000	usd
CY2024Q3	mlab	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	48750000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	73125000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	194000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	181.89
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M12D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	14000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	147.9
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	180000
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	184.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y10M24D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	229000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3428000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1230000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6816000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1779000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5413000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5387000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5405000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5379000
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	58000
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	0
	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	43000
	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	0
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5471000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5387000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5448000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5379000
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	562000
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	890000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	571000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	863000
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	384000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-95000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	901000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-483000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.101	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.072	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.117	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.214	pure
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	57833000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53165000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	116003000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103810000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	35455000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	32109000	usd
	us-gaap	Gross Profit GrossProfit	72704000	usd
	us-gaap	Gross Profit GrossProfit	63292000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	29738000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	32675000	usd

Files In Submission

Name	View Source	Status
0001437749-24-033745-index-headers.html	Edgar Link	pending
0001437749-24-033745-index.html	Edgar Link	pending
0001437749-24-033745.txt	Edgar Link	pending
0001437749-24-033745-xbrl.zip	Edgar Link	pending
ex_717746.htm	Edgar Link	pending
ex_717747.htm	Edgar Link	pending
ex_717748.htm	Edgar Link	pending
ex_717749.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mlab-20240930.xsd	Edgar Link	pending
mlab20240930_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
mlab-20240930_cal.xml	Edgar Link	unprocessable
mlab-20240930_def.xml	Edgar Link	unprocessable
mlab-20240930_pre.xml	Edgar Link	unprocessable
mlab-20240930_lab.xml	Edgar Link	unprocessable
mlab20240930_10q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLAB
MESA LABORATORIES INC /CO/ Stock $mlab

2024 Q4 Form 10-Q Financial Statement

#000143774924033745 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLAB MESA LABORATORIES INC /CO/ Stock $mlab

2024 Q4 Form 10-Q Financial Statement

#000143774924033745 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLAB
MESA LABORATORIES INC /CO/ Stock $mlab